These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14622362)

  • 1. Drug-induced bilateral transient myopia with the sulphonamide sulphasalazine.
    Santodomingo-Rubido J; Gilmartin B; Wolffsohn JS
    Ophthalmic Physiol Opt; 2003 Nov; 23(6):567-70. PubMed ID: 14622362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of sulphasalazine and methotrexate in the treatment of rheumatoid arthritis.
    Dougados M
    Z Rheumatol; 1998 Feb; 57(1):31-3. PubMed ID: 9566104
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH; Scott DL; Kingsley GH; Williams P; Wojtulewski J; Papasavvas G; Henderson E; Macfarlane D; Erhardt C; Young A; Plant MJ; Panayi GS
    Clin Exp Rheumatol; 2002; 20(3):351-8. PubMed ID: 12102471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M; Verhoeven AC; Markusse HM; van de Laar MA; Westhovens R; van Denderen JC; van Zeben D; Dijkmans BA; Peeters AJ; Jacobs P; van den Brink HR; Schouten HJ; van der Heijde DM; Boonen A; van der Linden S
    Lancet; 1997 Aug; 350(9074):309-18. PubMed ID: 9251634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of intramuscular and oral meloxicam in rheumatoid arthritis patients.
    Combe B; Vélicitat P; Garzón N; Bluhmki E
    Inflamm Res; 2001 Mar; 50 Suppl 1():S10-6. PubMed ID: 11339515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe drug hypersensitivity syndrome due to sulphasalazine in patient with rheumatoid arthritis].
    Gutierrez M; Filippucci E; Bugatti L; Bertolazzi C; Grassi W
    Reumatismo; 2009; 61(1):65-8. PubMed ID: 19370190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis.
    Huskisson EC; Ghozlan R; Kurthen R; Degner FL; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():29-34. PubMed ID: 8630633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
    Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulphasalazine desensitization in a paediatric patient with juvenile chronic arthritis.
    Kümmerle-Deschner J; Dannecker G
    Acta Paediatr; 1995 Aug; 84(8):952-4. PubMed ID: 7488828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
    McInnes IB; Porter D; Murphy EA; Thomson EA; Madhok R; Hunter JA; Pullar T; Capell HA
    Ann Rheum Dis; 1996 May; 55(5):328-30. PubMed ID: 8660109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis.
    Reginster JY; Distel M; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():17-21. PubMed ID: 8630631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis.
    Wojtulewski JA; Schattenkirchner M; Barceló P; Le Loët X; Bevis PJ; Bluhmki E; Distel M
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():22-8. PubMed ID: 8630632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rheumatic disease therapy without regret. Meloxicam dosage safety].
    MMW Fortschr Med; 2002 Nov; 144(46):66-7. PubMed ID: 12534086
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results.
    Georgescu C
    Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of multiple administration of intramuscular meloxicam: a comparison with intramuscular piroxicam in patients with rheumatoid arthritis or osteoarthritis.
    Ghozlan PR; Bernhardt M; Vélicitat P; Bluhmki E
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():51-5. PubMed ID: 8630638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sulphasalazine in patients with rheumatoid arthritis in China: a cross-sectional study].
    Liu T; Wang XR; An Y; Zhou YS; Zhang XY; Duan TJ; Zhu JX; Li XF; Wang LZ; Wang CH; Wang YF; Yang R; Wang GC; Lu X; Zhu P; Chen LN; Jin HT; Liu XY; Sun L; Chen HY; Cui LF; Shu R; Liu BL; Zhang ZL; Li GT; Li ZB; Yang J; Li JF; Jia B; Zhang FX; Tao JM; Han SL; Lin JY; Wei MQ; Liu XM; Ke D; Hu SX; Ye C; Yang XY; Li H; Huang CB; Gao M; Lai P; Li XF; Song LJ; Wang Y; Wang XY; Mu R; Su Y; Li ZG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):188-94. PubMed ID: 22516985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal neuropathy with prolonged sulphasalazine use.
    Liedorp M; Voskuyl AE; Van Oosten BW
    Clin Exp Rheumatol; 2008; 26(4):671-2. PubMed ID: 18799104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of clinical trials and benefit/risk ratio of meloxicam.
    Barner A
    Scand J Rheumatol Suppl; 1996; 102():29-37. PubMed ID: 8628979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and retention of combination triple disease-modifying anti-rheumatic drugs in new-onset rheumatoid arthritis.
    Cummins L; Katikireddi VS; Shankaranarayana S; Su KY; Duggan E; Videm V; Pahau H; Thomas R
    Intern Med J; 2015 Dec; 45(12):1266-73. PubMed ID: 26384029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bovine serum albumin-meloxicam nanoaggregates laden contact lenses for ophthalmic drug delivery in treatment of postcataract endophthalmitis.
    Zhang W; Zu D; Chen J; Peng J; Liu Y; Zhang H; Li S; Pan W
    Int J Pharm; 2014 Nov; 475(1-2):25-34. PubMed ID: 25158220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.